The role of p16 as putative biomarker for cervical neoplasia: A controversial issue?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/25020 |
Resumo: | Instituto Brasileiro de Medicina e Reabilitação. Rio de Janeiro, RJ, Brasil |
id |
CRUZ_d7f2ffbe3a71082dbf03bf255f52ba80 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/25020 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Gonçalves, Jessica E.S.Andrade, Cecilia Vianna deRossomano, Fabio B.Nuovo, Gerard J.Amaro Filho, Sergio M.Carvalho, Maria O. O.Nicol, Alcina Frederica2018-03-01T16:30:15Z2018-03-01T16:30:15Z2017GONÇALVES, Jessica E. S. et al. The role of p16 as putative biomarker for cervical neoplasia: A controversial issue?. MedicalExpress, v.4, n.6, M170601, 5p, Dec. 2017.2318-8111https://www.arca.fiocruz.br/handle/icict/2502010.5935/MedicalExpress.2017.06.012358-0429engMavera, Edições Científicas e Técnicas LtdaInfecção por HPVPapillomaviridaeBiomarcadoresNeoplasias do Colo do Úterolesão intra-epitelial cervicalp16 proteinHPV infectioncervical cancerbiomarkercervical intraepithelial lesionThe role of p16 as putative biomarker for cervical neoplasia: A controversial issue?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleInstituto Brasileiro de Medicina e Reabilitação. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto Nacional da Saúde da Mulher, Criança e Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional da Saúde da Mulher, Criança e Adolescente Fernandes Figueira. Rio de Janeiro, RJ, Brasil.State University Comprehensive Cancer Center. Columbus, OH, USA.Instituto Nacional de Câncer. Divisão de Genética. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ. Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Interdisciplinar de Pesquisas Médicas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ. Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Interdisciplinar de Pesquisas Médicas. Rio de Janeiro, RJ, Brasil.INTRODUCTION: Protein p16 has been extensively studied as a potential biomarker for precursor lesions to distinguish cervical Intraepithelial neoplasia (CIN) from their mimics. However, the use of p16 as prognostic biomarker for diagnosis of cervical cancer and precancer is controversial. This study focuses on the assessment of peer-reviewed scientific data related to the use of p16 to predict disease severity and its controversies. METHODS: We reviewed publications in MEDLINE/PubMed assessing the clinical, diagnostic and prognostic significance of p16 in CIN and cervical cancer; we included publications from 2009 to June 2017. RESULTS: The use of p16 as a prognostic marker is still unreliable, although it could be a useful tool for diagnosis of Cervical Intraepithelial Neoplasia lesions with undetermined morphology. Moreover, p16 appears to be a specific marker of high-risk oncogenic HPV infection. CONCLUSION: This review shows the potential utility and drawbacks of p16 for clinical practice and the diagnosis of cervical cancer. Further studies are required to substantiate the role of p16 in conjunction with other more sensitive and specific biomarkers for diagnosing CIN and predicting its progression.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/25020/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALalcinaf_nicol_etal_IOC_2017.pdfalcinaf_nicol_etal_IOC_2017.pdfapplication/pdf282043https://www.arca.fiocruz.br/bitstream/icict/25020/2/alcinaf_nicol_etal_IOC_2017.pdfa766894a85bdf3650c4e0d6878e5ecffMD52TEXTalcinaf_nicol_etal_IOC_2017.pdf.txtalcinaf_nicol_etal_IOC_2017.pdf.txtExtracted texttext/plain24149https://www.arca.fiocruz.br/bitstream/icict/25020/3/alcinaf_nicol_etal_IOC_2017.pdf.txtadd38e1df2001670bc5320d02f797d6dMD53icict/250202018-08-15 02:35:06.408oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-08-15T05:35:06Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
title |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
spellingShingle |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? Gonçalves, Jessica E.S. Infecção por HPV Papillomaviridae Biomarcadores Neoplasias do Colo do Útero lesão intra-epitelial cervical p16 protein HPV infection cervical cancer biomarker cervical intraepithelial lesion |
title_short |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
title_full |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
title_fullStr |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
title_full_unstemmed |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
title_sort |
The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? |
author |
Gonçalves, Jessica E.S. |
author_facet |
Gonçalves, Jessica E.S. Andrade, Cecilia Vianna de Rossomano, Fabio B. Nuovo, Gerard J. Amaro Filho, Sergio M. Carvalho, Maria O. O. Nicol, Alcina Frederica |
author_role |
author |
author2 |
Andrade, Cecilia Vianna de Rossomano, Fabio B. Nuovo, Gerard J. Amaro Filho, Sergio M. Carvalho, Maria O. O. Nicol, Alcina Frederica |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Gonçalves, Jessica E.S. Andrade, Cecilia Vianna de Rossomano, Fabio B. Nuovo, Gerard J. Amaro Filho, Sergio M. Carvalho, Maria O. O. Nicol, Alcina Frederica |
dc.subject.other.pt_BR.fl_str_mv |
Infecção por HPV Papillomaviridae Biomarcadores Neoplasias do Colo do Útero lesão intra-epitelial cervical |
topic |
Infecção por HPV Papillomaviridae Biomarcadores Neoplasias do Colo do Útero lesão intra-epitelial cervical p16 protein HPV infection cervical cancer biomarker cervical intraepithelial lesion |
dc.subject.en.pt_BR.fl_str_mv |
p16 protein HPV infection cervical cancer biomarker cervical intraepithelial lesion |
description |
Instituto Brasileiro de Medicina e Reabilitação. Rio de Janeiro, RJ, Brasil |
publishDate |
2017 |
dc.date.issued.fl_str_mv |
2017 |
dc.date.accessioned.fl_str_mv |
2018-03-01T16:30:15Z |
dc.date.available.fl_str_mv |
2018-03-01T16:30:15Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GONÇALVES, Jessica E. S. et al. The role of p16 as putative biomarker for cervical neoplasia: A controversial issue?. MedicalExpress, v.4, n.6, M170601, 5p, Dec. 2017. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/25020 |
dc.identifier.issn.pt_BR.fl_str_mv |
2318-8111 |
dc.identifier.doi.none.fl_str_mv |
10.5935/MedicalExpress.2017.06.01 |
dc.identifier.eissn.none.fl_str_mv |
2358-0429 |
identifier_str_mv |
GONÇALVES, Jessica E. S. et al. The role of p16 as putative biomarker for cervical neoplasia: A controversial issue?. MedicalExpress, v.4, n.6, M170601, 5p, Dec. 2017. 2318-8111 10.5935/MedicalExpress.2017.06.01 2358-0429 |
url |
https://www.arca.fiocruz.br/handle/icict/25020 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Mavera, Edições Científicas e Técnicas Ltda |
publisher.none.fl_str_mv |
Mavera, Edições Científicas e Técnicas Ltda |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/25020/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/25020/2/alcinaf_nicol_etal_IOC_2017.pdf https://www.arca.fiocruz.br/bitstream/icict/25020/3/alcinaf_nicol_etal_IOC_2017.pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 a766894a85bdf3650c4e0d6878e5ecff add38e1df2001670bc5320d02f797d6d |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009212721070080 |